Compare CLH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLH | ASND |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 14.7B |
| IPO Year | 1994 | 2014 |
| Metric | CLH | ASND |
|---|---|---|
| Price | $283.52 | $235.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 16 |
| Target Price | ★ $309.45 | $281.50 |
| AVG Volume (30 Days) | 553.1K | ★ 620.3K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $2,944,978,000.00 | N/A |
| Revenue This Year | $4.58 | $96.35 |
| Revenue Next Year | $4.30 | $44.91 |
| P/E Ratio | $240.17 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $201.34 | $158.16 |
| 52 Week High | $316.98 | $250.74 |
| Indicator | CLH | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 48.92 |
| Support Level | $277.65 | $234.08 |
| Resistance Level | $296.41 | $245.88 |
| Average True Range (ATR) | 7.54 | 9.40 |
| MACD | -2.16 | -0.05 |
| Stochastic Oscillator | 8.46 | 50.16 |
Clean Harbors Inc is an environmental and industrial services provider that provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. Environmental Services includes waste collection, transportation, treatment, recycling, and disposal, along with industrial maintenance services. Safety-Kleen Sustainability Solutions provides used oil collection and manufactures base oil, vacuum gas oil, and lubricants. The company generates the majority of its revenues from the Environmental Services segment and operates in the United States, with maximum revenue, and Canada.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.